713 related articles for article (PubMed ID: 10352758)
1. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
O'Sullivan S
Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
[TBL] [Abstract][Full Text] [Related]
3. Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
Misso NL; Aggarwal S; Thompson PJ; Vally H
Int Arch Allergy Immunol; 2009; 149(2):127-32. PubMed ID: 19127069
[TBL] [Abstract][Full Text] [Related]
4. Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction.
Parsons WG; Roberts LJ
J Immunol; 1988 Oct; 141(7):2413-9. PubMed ID: 3139758
[TBL] [Abstract][Full Text] [Related]
5. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
[TBL] [Abstract][Full Text] [Related]
6. Evidence of mast cell activation and leukotriene release after mannitol inhalation.
Brannan JD; Gulliksson M; Anderson SD; Chew N; Kumlin M
Eur Respir J; 2003 Sep; 22(3):491-6. PubMed ID: 14516140
[TBL] [Abstract][Full Text] [Related]
7. Analyses of prostaglandin D2 metabolites in urine: comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography-mass spectrometry.
O'Sullivan S; Mueller MJ; Dahlén SE; Kumlin M
Prostaglandins Other Lipid Mediat; 1999 May; 57(2-3):149-65. PubMed ID: 10410385
[TBL] [Abstract][Full Text] [Related]
8. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
9. Evidence for mast cell activation during exercise-induced bronchoconstriction.
O'Sullivan S; Roquet A; Dahlén B; Larsen F; Eklund A; Kumlin M; O'Byrne PM; Dahlén SE
Eur Respir J; 1998 Aug; 12(2):345-50. PubMed ID: 9727783
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of beclomethasone on hyperpnea-induced bronchoconstriction.
Kippelen P; Larsson J; Anderson SD; Brannan JD; Delin I; Dahlen B; Dahlen SE
Med Sci Sports Exerc; 2010 Feb; 42(2):273-80. PubMed ID: 19927031
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.
O'Sullivan S; Roquet A; Dahlén B; Dahlén S; Kumlin M
Clin Exp Allergy; 1998 Nov; 28(11):1332-9. PubMed ID: 9824404
[TBL] [Abstract][Full Text] [Related]
12. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
Kay AB
Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.
Shin TR; Kim JH; Kim CH; Hyun IG; Choi JH
J Thorac Dis; 2015 Jul; 7(7):1198-204. PubMed ID: 26380736
[TBL] [Abstract][Full Text] [Related]
14. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
Sanak M; Kiełbasa B; Bochenek G; Szczeklik A
Clin Exp Allergy; 2004 Dec; 34(12):1899-904. PubMed ID: 15663565
[TBL] [Abstract][Full Text] [Related]
15. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
Sladek K; Szczeklik A
Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
[TBL] [Abstract][Full Text] [Related]
16. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers.
Higashi N; Mita H; Ono E; Fukutomi Y; Yamaguchi H; Kajiwara K; Tanimoto H; Sekiya K; Akiyama K; Taniguchi M
J Allergy Clin Immunol; 2010 May; 125(5):1084-1091.e6. PubMed ID: 20304469
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma.
Beasley R; Varley J; Robinson C; Holgate ST
Am Rev Respir Dis; 1987 Nov; 136(5):1140-4. PubMed ID: 2960256
[TBL] [Abstract][Full Text] [Related]
19. Urinary inflammatory mediators and inhalation of hypertonic saline in children.
Mai XM; Böttcher MF; Bruhammar M; Nilsson L; Zetterström O
Allergy; 2005 Jan; 60(1):60-4. PubMed ID: 15575932
[TBL] [Abstract][Full Text] [Related]
20. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
